central nervous system uptake of intranasal glutathione in parkinson's disease nanotherapeutics for brain targeting and clinical studies glutathione in parkinson's disease Enhanced
glutathione in parkinson's disease Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy Drug Delivery and Translational Research Springer Nature Link ABSTRACTS PMC Intranasal Nano Delivery Systems: Emerging Strategies for Central Nervous System Disease Therapeutics PMC
Pay in 4 interest-free payments of $6.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



